Coston McIsaac & Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 803 |
|
|
2025
Q1 | – | Sell |
-2
| Closed | – | – | 803 |
|
|
2024
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 802 |
|
|
2024
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 794 |
|
|
2024
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 775 |
|
|
2024
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 757 |
|
|
2023
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 757 |
|
|
2023
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 764 |
|
|
2023
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 817 |
|
|
2023
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 832 |
|
|
2022
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 799 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 718 |
|
|
2022
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 498 |
|